Maxx Orthopedics Releases Covid-19 Statement as States Ramp Up Elective Surgeries
Norristown, PA (USA) May 14, 2020: Maxx Orthopedics, Inc., a rapidly expanding global orthopedics device company, released a statement today regarding COVID-19 and the resumption of elective surgeries.
As the impact of Covid-19 continues to proliferate globally and within the United States we would like to thank our dedicated healthcare warriors and essential workers who are working countless hours to provide care and resolve to those who need it most. Your commitment, sacrifice, and care for people is admirable and inspiring. We are forever grateful. At Maxx, we are committed to putting people first and supporting our colleagues and customers. Each day brings new updates regarding Covid-19. We will continue developing new procedures that work with our healthcare providers and abide by all new safety protocols so we can meet the new reality of healthcare post-Covid-19.
To that end, we have been working hard to develop initiatives that will lower costs and ease the burden to our customers for doing elective surgery. This includes tele-medicine friendly apps, ai-driven sizing, and reducing the number of “hands” required to execute a case.
We encourage the healthcare community to ask us how we can best serve you during these challenging times. We are here to support you to help provide patients with the best care possible.
For additional information, please visit www.maxxortho.com.
About Maxx Orthopedics
Maxx Orthopedics is the manufacturer of the Freedom Knee® System, Freedom QRS® and Libertas® Total Hip System. The company develops and markets innovative orthopedic medical devices with a focus on providing state-of-the-art implants and related solutions that best restore patient mobility while accommodating lifestyle, anatomical and economic needs. Maxx Medical, Pvt. Ltd., is the parent company of Maxx Orthopedics, Inc.